Diabetic Retinopathy Header Bar

Editorial Feature:

Diabetic Retinopathy

Changing Treatment Paradigms

How to Manage Patient Buy-In for Anti-VEGF Therapy

Show Description +

Rishi P. Singh, MD; Tarek S. Hassan, MD; and Nikolas J.S. London, MD, review the challenges they face in managing patient buy-in for the treatment of diabetic retinopathy.

Posted: 9/27/2018

Up Next in this Program

Take-Home Points From the BOULEVARD Trial

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD


Updates in Changing Treatment Paradigms for DR

Translating Data for Educating Patients With DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Reviewing the BOULEVARD Trial and RG7716

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Think Outside the Box: Treatment Options for DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Key Takeaways for Treating Patients With DR

Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

How to Manage Patient Buy-In for Anti-VEGF Therapy

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Take-Home Points From the BOULEVARD Trial

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

New Horizons for Treatment Options for DR

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Medical Management of DR: Case Discussions

Kiss Case: Anti-VEGF Agents in a Case of PDR

Caroline R. Baumal, MD, Charles C. Wykoff, MD, PhD, FACS, Szilard Kiss, MD

Chiang Case: Peripheral Neovascularization With PDR

Allen Chiang, MD, Charles C. Wykoff, MD, PhD, FACS, Joseph M. Coney, MD

Coney Cases: Laser Versus Anti-VEGF Treatment for Diabetic Patients

Allen Chiang, MD, Charles Fritch MD, Joseph M. Coney, MD

How to Manage Patient Buy-In for Anti-VEGF Therapy

Rishi P. Singh, MD; Tarek S. Hassan, MD; and Nikolas J.S. London, MD, review the challenges they face in managing patient buy-in for the treatment of diabetic retinopathy.

Posted: 9/27/2018


Please log in to leave a comment.